ABBOTT LABORATORIES — Director's Dealing 2008

Mar 21, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-03-20

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-03-20	Common shares without par value	M	822	$33.2314	Acquired	161179	Direct
2008-03-20	Common shares without par value	M	26601	$38.6258	Acquired	187780	Direct
2008-03-20	Common shares without par value	M	16672	$41.0317	Acquired	204452	Direct
2008-03-20	Common shares without par value	M	17395	$42.90	Acquired	221847	Direct
2008-03-20	Common shares without par value	M	17954	$42.94	Acquired	239801	Direct
2008-03-20	Common shares without par value	F	67591	$54.39	Disposed	172210	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-03-20	Option (right to buy)	$33.2314	M	822	Disposed	2013-02-13	Common shares (822)	Direct
2008-03-20	Option (right to buy)	$54.39	A	31465	Acquired	2013-02-13	Common shares (31465)	Direct
2008-03-20	Option (right to buy)	$38.6258	M	26601	Disposed	2014-03-30	Common shares (26601)	Direct
2008-03-20	Option (right to buy)	$54.39	A	21933	Acquired	2014-03-30	Common shares (21933)	Direct
2008-03-20	Option (right to buy)	$41.0317	M	16672	Disposed	2014-02-19	Common shares (16672)	Direct
2008-03-20	Option (right to buy)	$54.39	A	14193	Acquired	2014-02-19	Common shares (14193)	Direct
2008-03-20	Option (right to buy)	$42.90	M	17395	Disposed	2013-02-13	Common shares (17395)	Direct
2008-03-20	Option (right to buy)	$42.94	M	17954	Disposed	2013-02-13	Common shares (17954)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	13915	Indirect
Common shares without par value	295	Indirect
Common shares without par value	296	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 19, 2008.

F2: Reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.